Skip to content
Search

Latest Stories

Blood tests for Alzheimer's diagnosis could be available on NHS within five years

These tests can diagnose Alzheimer’s disease earlier and more accurately than current methods 

 A £5m project has been launched to introduce new blood tests in the National Health Service (NHS) that can diagnose Alzheimer’s disease.


The blood tests could be available on the NHS within five years and they can diagnose the disease earlier and more accurately than current methods, experts have said.

Alzheimer’s Research UK, the Alzheimer’s Society and the National Institute of Health and Care Research have jointly launched the project.

Susan Kohlhaas, Executive Director of Research and Partnerships at Alzheimer’s Research UK, said that the NHS doesn’t possess the “required levels of diagnostic infrastructure” to cope with the “growing demand” for dementia diagnosis.

“Low-cost tools like blood tests that are non-invasive and simpler to administer than current gold standard methods are the answer to this,” she added.

Fiona Carragher, Director of Research and Influencing at the Alzheimer’s Society, said implementing a blood test for dementia into UK healthcare systems would be “a truly game-changing win in the fight against this devastating disease.”

Diagnosis of Alzheimer’s to become easier

According to Kohlhaas, diagnosis of Alzheimer’s is currently done through brain imaging or lumbar punctures that can be “invasive and come with uncomfortable side effects.”

Lumbar puncture is a process of diagnosis in which a sample of spinal fluid is drawn from the lower back.

The 2023 Dementia Attitudes Monitor survey also revealed that blood tests for diagnosing dementia would be much more acceptable to the public than the existing tests.

More than half of UK adults would be reluctant to undergo a lumbar puncture, but over 90 per cent of respondents would be willing to take a blood test, the survey found.

Several blood tests for Alzheimer’s are currently in the research stages. Some of these look for specific proteins, such as amyloid and tau, that occur before dementia symptoms appear.

However, so far, no test has been clinically validated in the UK, or made available to patients in the NHS.

Funds for the new project have been raised by players of People’s Postcode Lottery, and it will involve working with world-class researchers, Alzheimer’s Research UK stated.

More For You

NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less